Head & Neck Cancer
Researchers' findings from Canada, the United Kingdom and Germany advance head & neck cancer research
Published in Cancer Weekly, May 29th, 2006
Study 1: Head and neck squamous cell carcinoma (SCCHN) could be treated by low-dose cisplatin and three-dimensional conformal radiotherapy.
"Our center sought to implement a simple chemoradiotherapy schedule for patients with locally advanced SCCHN with minimal toxicity to achieve rates of overall survival comparable to other schedules. The chemoradiotherapy schedule consisted of daily radiation to 70 Gy over 7 weeks with concurrent cisplatin 20 mg/m2 during days 1 to 4 of weeks 1 and 5," investigators in Canada reported.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-05-29)
More Articles from Cancer Weekly
- Cancer Therapy
BMS-275183 showed promising antitumor activity - Hepatocarcinogenesis
Hepatocarcinogenesis linked to dysregulation of the Hedgehog pathway - Lung Cancer
Lung carcinogenesis linked to reduced HAUSP gene expression - Ovarian Cancer
Epithelial ovarian cancer survival lowered with stromal matrix metalloproteinase overexpression - AIDS-Related Kaposi Sarcoma
MMP inhibitor COL-3 active and well tolerated in AIDS-related Kaposi sarcoma - Acoustic Neuroma
Acoustic neuroma long-term outcome after stereotactic radiosurgery assessed - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
